| Clinical data | |
|---|---|
| Trade names | Aldrisone |
| Other names | Delta-medrysone;[1] 6α-Methyl-11β-hydroxypregna-1,4-diene-3,20-dione; 6α-Methyl-11β-hydroxy-Δ1-progesterone |
| Routes of administration | Topical,ophthalmic[1][2] |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.047.587 |
| Chemical and physical data | |
| Formula | C22H30O3 |
| Molar mass | 342.479 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Endrisone (INN; also known asendrysone (USAN); brand nameAldrisone) is asynthetic,steroidalglucocorticoid which is or has been marketed inItaly bySIFI.[1][2][3] It is used as atopical andophthalmicanti-inflammatory drug in the treatment ofskin andeye conditions, respectively.[1][2]